Hepatic Encephalopathy

Butterworth, Roger F.
September 2003
Alcohol Research & Health;2003, Vol. 27 Issue 3, p240
Academic Journal
Hepatic encephalopathy (HE) is a brain disorder caused by chronic liver failure, particularly in alcoholics with cirrhosis, which results in cognitive, psychiatric, and motor impairments. In these patients, the number of functional liver cells is reduced, and some blood is diverted around the liver before toxins are removed. As a result, toxins such as ammonia and manganese can accumulate in the blood and enter the brain, where they can damage nerve cells and supporting cells called astrocytes. Positron emission tomography analyses have determined that ammonia levels are elevated in the brains of HE patients; ammonia accumulation can alter the expression of various important brain genes. Magnetic resonance images show that manganese is deposited in a brain area called the globus pallidus; manganese deposits may be responsible for structural changes in the astrocytes that are characteristic of HE. Treatment of patients with HE involves measures to lower ammonia levels in the blood, medications to counteract ammonia's effects on brain cell function, devices to compensate for liver dysfunction, and liver transplantation. INSET: Altered Gene Expression in the Brain Resulting From Alcoholic....


Related Articles

  • Congenital extrahepatic portosystemic shunts. Murray, Conor P.; Shi-Joon Yoo; Babyn, Paul S.; Yoo, Shi-Joon // Pediatric Radiology;Sep2003, Vol. 33 Issue 9, p614 

    Background: A congenital extrahepatic portosystemic shunt (CEPS) is uncommon. A type 1 CEPS exists where there is absence of intrahepatic portal venous supply and a type 2 CEPS where this supply is preserved. The diagnosis of congenital portosystemic shunt is important because it...

  • Possible Response of Acute Psychosis in Hepatic Encephalopathy to Levodopa. Douer, Dan; Weinberger, Abraham; Naftalin, Julius; Pinkhas, Jack; De Vries, Andre // American Journal of Gastroenterology;Nov1976, Vol. 66 Issue 5, p473 

    A favorable response to levodopa in two episodes of hepatic encephalopathy, the latter presenting as acute psychosis, is described in a patient with Budd-Chiari syndrome.

  • ROLE OF N-ACETYLCYSTIENE IN ACUTE HEPATIC FAILURE. Alvi, Haris; Talib, Abu; Khan, Fazal Wahab // Medical Channel;Jan2012, Vol. 18 Issue 1, p37 

    Introduction: Acute liver failure (ALF) may be fulminant. Fulminant hepatic failure is characterized by the development of hepatic encephalopathy within 8 weeks after the onset of acute liver disease. Coagulopathy is invariably present. A thiol-containing agent, Nacetylcysteine (NAC) scavenges...

  • Reversal of transjugular intrahepatic portosystemic shunt (TIPS)-induced hepatic encephalopathy using a strictured self-expanding covered stent. Cox, Mitchell W.; Soltes, George D.; Lin, Peter H.; Bush, Ruth L.; Lumsden, Alan B. // CardioVascular & Interventional Radiology;Nov2003, Vol. 26 Issue 6, p539 

    Hepatic encephalopathy is a known complication following percutaneous transjugular intrahepatic portosystemic shunt (TIPS) placement. We describe herein a simple and effective strategy of TIPS revision by creating an intraluminal stricture within a self-expanding covered stent, which is deployed...

  • Current thoughts on surgery for portal hypertension.  // British Medical Journal;10/15/1977, Vol. 2 Issue 6093, p978 

    Comments regarding the surgery for portal hypertension. Association between the failure of postcaval anastomosis (PCA) and the high incidence of encephalopathy; Research on the value of PCA; Presentation of randomized controlled trials for patients with portal hypertension.

  • PORTOSYSTEMIC SHUNTS: FIVE- AND TEN-YEAR FOLLOW-UPS OF 68 CASES. Wratten, Gary P.; Jahnke, Edward J.; Whelan, Thomas J. // American Journal of Gastroenterology;May1964, Vol. 41 Issue 5, p519 

    Presents information on the long-term follow-up studies on patients undergoing portosystemic shunt procedures for intrahepatic portal obstruction. Description of the long-term effects of portosystemic shunt; Information on the survival and mortality rate of portosystemic shunt; Etiology of the...

  • SEVERE RECURRENT HEPATIC ENCEPHALOPATHY THAT RESPONDED TO ORAL BRANCHED CHAIN AMINO A Cms. Chalasani, N.; Gitlin, Norman // American Journal of Gastroenterology;Jun1996, Vol. 91 Issue 6, p1266 

    Hepatic encephalopathy is a neuropsychiatric syndrome occurring in patients with acute or chronic liver disease. Its pathogenesis remains unclear; however, it appears to be multifactorial. There are several conventional treatments for this condition, such as lactulose, neomycin, and protein...

  • Vascular Plug-Assisted Retrograde Transvenous Obliteration of Portosystemic Shunts for Refractory Hepatic Encephalopathy: A Case Report. Park, Jonathan K.; Sung-Ki Cho; Stephen Kee; Lee, Edward W. // Case Reports in Radiology;2014, p1 

    While balloon-assisted retrograde transvenous obliteration (BRTO) has been used for two decades in Asia for the management of gastric variceal bleeding, it is still an emerging therapy elsewhere. Given the shunt closure brought about by the procedure, BRTO has also been used for the management...

  • Progressive Encephalopathy With Edema, Hypsarrhythmia, and Optic Nerve Atrophy (PEHO)-Like Syndrome: What Diagnostic Characteristics Are Defining? D'Arrigo, Stefano; Grazia, Bruzzone Maria; Faravelli, Francesca; Riva, Daria; pantaleoni, Chiara // Journal of Child Neurology;May2005, Vol. 20 Issue 5, p454 

    Progressive encephalopathy with edema, hypsarrhythmia, and optic nerve atrophy (PEHO) syndrome is a rare, apparently autosomal recessive condition in which characteristic dysmorphic features are associated with subcutaneous edema, visual deficit, early arrest of psychomotor development,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics